Register Login
Register to leave comments
  • News bot Oct. 29, 2025, 10:35 a.m.

    🏢 Surface Oncology Inc (was by Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) on 16/06/2023) (SURF) - Form 10-Q Quarterly Report

    Quarterly financial filing submitted to the SEC

    📋 Filing Information

    📄 Form Type: 10-Q
    📅 Filing Date: 2022-08-03
    📊 Period of Report: 2022-06-30
    ⏰ Accepted: N/A
    📊

    Key Financial Metrics (Period-over-Period Comparison)

    Metric Current Period Previous Period Change ($) Change (%) Trend
    Net Income/Loss $-34.54M $-19.01M $-15.53M -81.67% 📈
    Total Assets $190.85M $193.98M $-3.13M -1.61% ↘️
    Total Liabilities $71.95M $68.26M $3.68M +5.40% 📉
    Stockholders' Equity $148.09M $-96.80M $244.89M +252.98% 📈
    Operating Income/Loss $-33.15M $-17.79M $-15.36M -86.34% 📈
    R&D Expense $23.21M $34.82M $-11.61M -33.34% 📈
    Earningspersharebasic $-0.81 $-0.37 $-0.44 -118.92% 📉
    Earningspersharediluted $-0.81 $-0.37 $-0.44 -118.92% 📉
    📈

    Financial Trend Analysis

    🔻 Reported net loss for the period • ⚖️ Liability growth outpaced asset growth

    📎 View Full 10-Q Filing on SEC.gov

    Access the complete official filing document

Search

News categories